Tag Archives: announces

U.S. Attorney General Announces Continued U.S. Funding of Law Enforcement Efforts at 3rd Ministerial of Northern Triangle Attorneys General, as Guatemala Prepares to Abolish Anti-Corruption Prosecutor

On May 16, 2019, U.S. Attorney General William P. Barr, during the 3rd Ministerial of the Northern Triangle Attorneys General announced that, as part of a coordinated law enforcement action known as Operation Regional Shield,President Trump has approved continued funding … Continue reading

Posted in International Law | Tagged , , , , , , , , , , , , , , , , | Leave a comment

EC JRC Announces Publication of Article on Measuring Nanoparticles in Medicinal Products

The European Commission’s (EC) Joint Research Center (JRC) announced on May 10, 2019, publication of an article entitled “Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL.  A step by step approach combining … Continue reading

Posted in Environmental Law | Tagged , , , , , , | Leave a comment

Germany Announces Research Project to Establish Criteria for Assessment of the Human Health and Environmental Risks of Novel (Nano) Materials

On April 29, 2019, the German Federal Institute for Risk Assessment (BfR) announced InnoMat.Life, a joint research project to establish criteria for an efficient assessment of the human health and environmental risks of novel (nano) materials.  The Federal Ministry of … Continue reading

Posted in Environmental Law | Tagged , , , , , , , , , , , , , | Leave a comment

SEC Announces Fraud Charges in Ticket Resale Investment Scam

The Securities and Exchange Commission today charged a New York City man with continuing a previously charged scheme, stealing millions of dollars from investors who were allegedly falsely promised their funds would be used for the purchase and resale of tickets … Continue reading

Posted in Banking and Finance law | Tagged , , , , , , | Leave a comment

FDA Announces Public Hearing on Regulation of Cannabis and Cannabis-Derived Products

The Food and Drug Administration (FDA) will hold a public hearing on May 31, 2019, “to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”1 This offers … Continue reading

Posted in Administrative law | Tagged , , , , | Leave a comment